Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Intangibles (2016 - 2025)

Historic Intangibles for Arrowhead Pharmaceuticals (ARWR) over the last 16 years, with Q4 2025 value amounting to $6.4 million.

  • Arrowhead Pharmaceuticals' Intangibles fell 2090.45% to $6.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $6.4 million, marking a year-over-year decrease of 2090.45%. This contributed to the annual value of $6.9 million for FY2025, which is 1986.69% down from last year.
  • Latest data reveals that Arrowhead Pharmaceuticals reported Intangibles of $6.4 million as of Q4 2025, which was down 2090.45% from $6.9 million recorded in Q3 2025.
  • In the past 5 years, Arrowhead Pharmaceuticals' Intangibles registered a high of $14.5 million during Q1 2021, and its lowest value of $6.4 million during Q4 2025.
  • For the 5-year period, Arrowhead Pharmaceuticals' Intangibles averaged around $10.5 million, with its median value being $10.5 million (2023).
  • As far as peak fluctuations go, Arrowhead Pharmaceuticals' Intangibles tumbled by 1048.74% in 2021, and later tumbled by 2090.45% in 2025.
  • Arrowhead Pharmaceuticals' Intangibles (Quarter) stood at $13.2 million in 2021, then dropped by 12.85% to $11.5 million in 2022, then decreased by 14.74% to $9.8 million in 2023, then decreased by 17.28% to $8.1 million in 2024, then fell by 20.9% to $6.4 million in 2025.
  • Its Intangibles was $6.4 million in Q4 2025, compared to $6.9 million in Q3 2025 and $7.3 million in Q2 2025.